News

June 1, 2016June 3, 2016

Salford Lung Study Shows Reduction in COPD Exacerbations with Relvar Ellipta

COPD, News

GlaxoSmithKline reported positive results from the pioneering Salford Lung Study (SLS) evaluating Relvar Ellipta 100/25 mcg for the treatment of exacerbations in patients with chronic obstructive pulmonary disease (COPD). Relvar is ... Read more

May 31, 2016May 31, 2016

Lung Metastasis in Mice Prevented by Targeting a Key Cancer Protein, Researchers Find

Lung Cancer, News

Researchers at Brown University demonstrated that controlling a key protein involved in cancer, through the activation of a specific immune response, can prevent cancer metastasis in mice’s lungs. The findings are described in ... Read more

May 31, 2016May 31, 2016

‘CF Champions: Navigating the Journey, Together’ Launched by Walgreens

Cystic Fibrosis, News

During The Cystic Fibrosis Foundation’s National CF Awareness Month in May, Walgreens launched “CF Champions: Navigating the Journey, Together,” a campaign to support champion patients and caregivers affected by cystic fibrosis (CF). Cystic ... Read more

May 31, 2016May 31, 2016

Raising Pulmonary Hypertension Awareness at ‘Breathless on Broadway’ Event

News, Pulmonary Hypertension

The 2nd annual “Breathless on Broadway,” an event devoted to raise awareness about pulmonary hypertension (PH), will take place this year on June 6 at Sardi’s Restaurant in NYC. The ... Read more

May 27, 2016May 27, 2016

Phase 2 Trial for Oral Cystic Fibrosis Treatment Gets Canada’s Green Light

Cystic Fibrosis, News

The Canadian biopharmeceutical corporation ProMetic Life Sciences has been authorized by Health Canada to begin a study on PBI-4050, its orally active anti-fibrotic investigational drug for the treatment of cystic fibrosis (CF). ... Read more

May 27, 2016May 27, 2016

Severe Asthma Reduced in Phase 3 Benralizumab Tests

Asthma, News

AstraZeneca recently announced that the new severe asthma medicine benralizumab met the primary endpoints in two Phase 3 registration trials. Findings of the trials called SIROCCO and CALIMA, revealed that the monoclonal antibody compound ... Read more

May 26, 2016May 26, 2016

CPRIT Funds Two Lung Cancer Studies at MD Anderson with $10.6M

Lung Cancer, News

The Cancer Prevention and Research Institute of Texas (CPRIT) will fund two collaborative studies with $6 million and $4.6 million grants, for research targeting critical issues in lung cancer (LC) to be ... Read more

May 26, 2016May 26, 2016

Promising Scleroderma Clinical Trial May Improve Hand Dysfunction

News, Scleroderma

Cytori Therapeutics provided a recent update on results from clinical trials assessing the use of Cytori Cell Therapy (ECCS-50) in the treatment of scleroderma-related hand dysfunction. The presentation was made during the 104th Annual Meeting of the ... Read more

May 26, 2016May 26, 2016

Lung Cancer Drug Alecensa Shows Superior to Crizotinib, Study Indicates

News

The biotechnology company Genentech recently announced that its product Alecensa (alectinib) was superior in reducing disease worsening risk or death in a specific type of lung cancer, compared to treatment with crizotinib. Researchers measured the ... Read more

May 25, 2016May 25, 2016

Winners of Cystic Fibrosis STRIVE Awards Announced by PTC Therapeutics

Cystic Fibrosis, News

PTC Therapeutics recently announced the winners of the company’s Global Strategies to Realize Innovation, Vision and Empowerment (STRIVE) Awards Program, supporting nonprofits serving the cystic fibrosis (CF) community. The celebration overlaps ... Read more